|
|
|
Pharmaceutical Manufacturing and Packing Sourcer |
|
|
|
|
|
 |
| |
|
|
|
|
Industry Insight
Robert Harris, PMPS Industry Advisor, highlights the importance of patient-centricity and picks out key articles from this issue that address this topic.
|
|
|
|
|
mHealth and Smart Technology
Breathing New Life into Asthma Care
Ali Moiyed at Aerobit Health uncovers how connected devices could enhance patient compliance. With a particular focus on inhalers, he argues that this could be one way in which the pharma industry can keep up with advances in technology.
|
|
|
Optimising Inhalation Therapy
Partial to Particles
Breath-actuated mechanisms are becoming increasingly common in inhalation devices due to their beneficial impact on fine particle doses. Dr David Lewis, Alan Tweedie and Francesca Mason at Chiesi investigate their potential.
|
|
|
|
The Falsified Medicines Directive
Is Europe Ready?
As the Falsified Medicines Directive deadline looms ever closer, Christoph Krähenbühl at 3C Excellis Europe clarifies what everyone, from manufacturers to wholesalers and pharmacists, need to do to ensure that the continent is prepared.
|
|
|
|
Electronic Batch Records
Paper Chase
COPA-DATA’s Robert Harrison argues for the transition from paper-based documentation to digitised production records in a bid to improve regulatory compliance and the management of data.
|
|
|
|
Outsourcing Supply Chains
Branching Out
Developing robust supply chains while simultaneously reducing expenditure and meeting global compliance can be challenging. Henry Moran and Amy Shortman of ASC Associates share their thoughts on why turning to outsourcing could be the answer.
|
|
|
Anti-Counterfeiting Measures
Security Breach
As a result of increased globalisation, pharma firms are constantly being put under greater pressure to provide a secure end-to-end supply chain. Although a daunting challenge, Pinkerton’s Steve Ward explains how this can be achieved to ensure drug safety and mitigate the risk of large economic losses.
|
|
|
Innovative Supply Chains
New Thinking
Jan Denecker at UPS Europe discusses the significance of flexibility in the supply chain as a result of today’s shift towards increasingly complex drugs. Manufacturers and third-party logistics providers must be ready to work together to create the efficiency needed.
|
|
|
|
Advancing Patient Protection
Easy Access
Amcor’s Colin Reed and Greg Rosati investigate the vital role that packaging plays in compliance. Often seen as an inconvenient part of the supply chain, they uncover why it should be treated as more than simply fulfilling a regulatory need.
|
|
|
Child-Resistant Packaging
Open and Close
In order to develop child-resistant packaging that is also easy to use for the elderly, continuous testing is key. Stephen Wilkins at Davies Development and Testing sheds some light on the complications with regards to staying compliant.
|
|
|
Packaging Design
First Impression
Conveying important information to patients through packaging and labelling is an arduous task in the pharma industry. Essentra’s Alan Davies explains why getting it right is so important in terms of design and compliance.
|
|
|
Patient-Centred Design
Packaging for People
Dr Karel van der Waarde at Graphic Design-Research elucidates why it is necessary to consider the end user as well as legal and economic packaging requirements so that medicines can be handled safely, correctly and efficiently.
|
|
|
|
Event Preview
Join the Crowd
Valerio Del Vecchio at the PPMA Group presents an enticing look at the upcoming PPMA Show and why Birmingham is the place to be this September.
|
|
|
|
|
End of the Line
Manufacturing a Renaissance
Pharma keeps on innovating, but PMPS Industry Advisor Robert Harris asks if this is enough for the sector to stay on par with other areas.
|
|
|
|
Clinical Supply Challenges
Under Control
The manufacture and distribution of controlled drugs is tightly governed, but regulations vary around the world and tend to cause a considerable amount of complexity. PCI Clinical Services’ Rich Nelson explores why experienced supply partners are vital in this field.
|
|
|
Clinical Trial Supply
Supply and Demand
SIRO Clinpharm’s Partha Chatterjee investigates the importance of collaboration between clinical operations and clinical trial supply teams in order to achieve more effective and efficient studies.
|
|
|
|
|
|
 |
|
|
 |
News and Press Releases |
 |
Signant Health Appoints Lawrence Miller as Chief Technology Officer
LONDON & PHILADELPHIA – June 13, 2019: Signant Health,
formerly CRF Bracket, has appointed Lawrence Miller as Chief Technology
Officer. Signant unites electronic Clinical Outcomes Assessment (eCOA),
eConsent, Patient Engagement, Interactive Response Technology (IRT),
Clinical Supply Management and Endpoint Quality into the industry’s most
comprehensive patient-centric suite of technology solutions and
services. An accomplished innovator, Miller brings unique vision and
expertise to a Signant team already committed to advancing clinical
research with its next-generation technology portfolio.
More info >> |
|
 |
White Papers |
 |
|
Clinical Trial Site Contracting: The Conservative, Progressive and Hybrid Models
DrugDev
For the last 20 years, pharmaceutical companies have turned to a variety of clinical outsourcing solutions to reduce costs and improve timelines, enabling them to focus on their core value of research and development. In today’s tightly competitive market, companies are constantly striving for ways to further cut costs and reduce study startup cycle times, while maintaining quality.
One of the key cost factors in global R&D spending, estimated at around $102 billion per Kalorama market research, is the cost of conducting clinical trials. CRO’s, which account for about 30% of the total R&D spending, have risen to the challenge of the clinical, technical and administrative management of these trials. But some pharmaceutical companies question how much control to relinquish to vendor partners, especially in the legal arena, due to potential ramifications.
More info >> |
|
 |
Industry Events |
 |
The Universe of Pre-filled Syringes and Injection Devices
22-23 October 2019, The Swedish Exhibition & Congress Centre Gothia Towers Hotel
PDA’s Universe of Pre-filled Syringes and Injection
Devices has become the must-attend meeting for everyone
working in the field, and is now the world’s largest conference on this subject
More info >> |
|
|
